Important decrease in invariant natural killer T, CD4+ regulatory T cells, CD8+ regulatory T cells, gamma-delta T cells, and CD4+ T lymphocytes in HIV-negative patients with hemophilia.

: Hereditary hemophilias are X-linked inherited bleeding disorders defined as deficiencies of the coagulation factors VIII or IX. They are characterized by easy to provoke or spontaneous bleeding. HIV infection in hemophilic patients is a risk factor for the reduction of CD4+ T cells. There is no information regarding the cellular immune function in HIV-negative patients with hemophilia. To evaluate the number of lymphocyte subsets in adult patients with hemophilia A or B as compared with healthy donors. 39 Adult hemophilics and 27 healthy donors were included. Lymphocyte subsets [CD4 and CD8 T cells, natural killer cells, natural killer T (NKT) cells, invariant NKT (iNKT) cells, gamma-delta T (γδT) cells, type 1 and 2 dendritic cells, CD14 monocytes, CD4 and CD8 regulatory T cells (Tregs), and B cells], were analyzed by flow cytometry. A significant decrease of CD4+ T lymphocytes, γδT cells, iNKT cells, CD4+ and CD8+ Tregs was observed in patients with hemophilia. Those patients having factor VIII inhibitor had the lowest CD4+ Treg and CD8+ Treg counts. CD14 monocytes were increased, as well as iNKT and type 2 dendritic cells in obese-overweight hemophilics. CD4+ lymphocytes, iNKT, γδT cells, and Tregs (CD4+ and CD8+), are significantly decreased in patients with hemophilia. Depletion of Tregs is more important in patients with factor VIII inhibitor. Physicians caring for hemophilia patients should realize that, even when they are not suffering infections frequently, may have early evidence of cellular immunodeficiency.

[1]  J. Pilch,et al.  Macrophage Polarization is Deregulated in Haemophilia , 2019, Thrombosis and Haemostasis.

[2]  G. Young,et al.  Novel therapies and current clinical progress in hemophilia A , 2018, Therapeutic advances in hematology.

[3]  O. Christophe,et al.  Emicizumab, a bispecific antibody recognizing coagulation factors IX and X: how does it actually compare to factor VIII? , 2017, Blood.

[4]  Xiaomei Wang,et al.  In vivo induction of regulatory T cells for immune tolerance in hemophilia. , 2016, Cellular immunology.

[5]  C. Leissinger.  Advances in the clinical management of inhibitors in hemophilia A and B. , 2016, Seminars in hematology.

[6]  J. Astermark,et al.  The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A , 2014, Journal of thrombosis and haemostasis : JTH.

[7]  E. Santagostino,et al.  Inhibitors – genetic and environmental factors , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

[8]  K. Ding,et al.  Higher frequency of CD4(+)CD25(high) Treg cells in hemophilia patients with factor VIII inhibitor. , 2014, Genetics and molecular research : GMR.

[9]  G. Escobedo,et al.  Serum IL-12 Is Increased in Mexican Obese Subjects and Associated with Low-Grade Inflammation and Obesity-Related Parameters , 2013, Mediators of inflammation.

[10]  M. Recht,et al.  Overweight and obesity in hemophilia: a systematic review of the literature. , 2011, American journal of preventive medicine.

[11]  C. Miao.  Immunomodulation for inhibitors in hemophilia A: the important role of Treg cells , 2010, Expert review of hematology.

[12]  Linrong Lu,et al.  Generation and Regulation of CD8+ Regulatory T Cells , 2008, Cellular and Molecular Immunology.

[13]  J. Orozco-Alcalá,et al.  Inactivity is a risk factor for low bone mineral density among haemophilic children , 2008, British journal of haematology.

[14]  J. G. van der Bom,et al.  Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study. , 2007, Blood.

[15]  J. Astermark,et al.  Polymorphisms in the CTLA‐4 gene and inhibitor development in patients with severe hemophilia A , 2007, Journal of thrombosis and haemostasis : JTH.

[16]  J. Astermark,et al.  Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A. , 2006, Blood.

[17]  K. Clément,et al.  Review article: Is obesity an inflammatory illness? Role of low‐grade inflammation and macrophage infiltration in human white adipose tissue , 2006 .

[18]  J. Astermark,et al.  Polymorphisms in the IL-10 but not in the IL-1{beta} and IL-4 genes are associated with inhibitor development in patients with hemophilia A. , 2006 .

[19]  J. Astermark.  Overview of inhibitors. , 2006, Seminars in hematology.

[20]  K. Clément,et al.  Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. , 2006, BJOG : an international journal of obstetrics and gynaecology.

[21]  C. Kempton,et al.  Cellular immune responses in hemophilia: why do inhibitors develop in some, but not all hemophiliacs? , 2005, Journal of thrombosis and haemostasis : JTH.

[22]  K. Kavaklı,et al.  The effect of clotting factor concentrates on the immune system in HIV‐negative haemophilics , 2005, Haemophilia : the official journal of the World Federation of Hemophilia.

[23]  M. Kronenberg,et al.  Going both ways: immune regulation via CD1d-dependent NKT cells. , 2004, The Journal of clinical investigation.

[24]  G. Opelz,et al.  Dissociation of CD4(+) cell counts from viral load and association with immune complexes in HIV(+) hemophilia patients. , 2004, Immunology letters.

[25]  T. Muneta,et al.  Effect of hypoxia on monocyte chemotactic protein-1 (MCP-1) gene expression induced by Interleukin-1β in human synovial fibroblasts , 2003, Inflammation Research.

[26]  V. Blanchette,et al.  Intensive exposure to factor VIII is a risk factor for inhibitor development in mild hemophilia A , 2003, Journal of thrombosis and haemostasis : JTH.

[27]  K. Pasi,et al.  Haemophilias A and B , 2003, The Lancet.

[28]  M. Kronenberg,et al.  The unconventional lifestyle of NKT cells , 2002, Nature Reviews Immunology.

[29]  E G Tuddenham,et al.  The hemophilias--from royal genes to gene therapy. , 2001, The New England journal of medicine.

[30]  G. Opelz,et al.  Association of immune complexes and plasma viral load with CD4+ cell depletion, CD8+ DR+ and CD16+ cell counts in HIV+ hemophilia patients. Implications for the immunopathogenesis of HIV-induced CD4+ lymphocyte depletion. , 2001, Immunology letters.

[31]  C. M. Steel,et al.  Immunological studies in HIV seronegative haemophiliacs: relationships to blood product therapy , 1992, British journal of haematology.

[32]  C. Forbes,et al.  Impaired cell mediated immunity in haemophilia in the absence of infection with human immunodeficiency virus. , 1986, British medical journal.

[33]  G. Zlabinger,et al.  A functional defect in the early phase of the immune response observed in patients with hemophilia A. , 1986, Clinical immunology and immunopathology.

[34]  R. Prescott,et al.  ABNORMALITIES OF CIRCULATING LYMPHOCYTE SUBSETS IN HAEMOPHILIACS IN AN AIDS-FREE POPULATION , 1984, The Lancet.

[35]  E. Lennette,et al.  Immunologic abnormalities in patients with hemophilia A. , 1983, The Journal of pediatrics.

[36]  R. Gershon,et al.  Cell interactions in the induction of tolerance: the role of thymic lymphocytes. , 1970, Immunology.